Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
PharmaEssentia | Taiwan | Healthcare | Biotechnology & Medical Research | NT$187.08B | 62.7x | 0.12 | NT$562 | 1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 39.1% Upside | Upgrade to Pro+ | |
Bora Pharmas | Taiwan | Healthcare | Pharmaceuticals | NT$80.93B | 20.2x | 0.68 | NT$783 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 32.7% Upside | Upgrade to Pro+ | |
Lotus Pharma | Taiwan | Healthcare | Pharmaceuticals | NT$67.93B | 13.6x | 0.6 | NT$263 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 29.9% Upside | Upgrade to Pro+ | |
Oneness Biotech | TPEX | Healthcare | Pharmaceuticals | NT$37.81B | -32.4x | -2.59 | NT$79.10 | -2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Lumosa Therapeutics | TPEX | Healthcare | Biotechnology & Medical Research | NT$34.20B | -84.7x | 0.28 | NT$202.50 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 14.4% Upside | Upgrade to Pro+ | |
Polaris Group | Taiwan | Healthcare | Biotechnology & Medical Research | NT$32.72B | -14.5x | 0.2 | NT$43.85 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Center Laboratories | TPEX | Healthcare | Pharmaceuticals | NT$29.25B | -68.6x | -1.23 | NT$40.60 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Pegavision | Taiwan | Healthcare | Healthcare Equipment & Supplies | NT$28.67B | 15.7x | 0.71 | NT$367.50 | -0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 10.7% Upside | Upgrade to Pro+ | |
TaiMed Biologics | TPEX | Healthcare | Biotechnology & Medical Research | NT$26.63B | -181.2x | -9.25 | NT$97.50 | 2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 15.1% Upside | Upgrade to Pro+ | |
EirGenix | TPEX | Healthcare | Pharmaceuticals | NT$23.21B | -23.5x | 0.4 | NT$75.80 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
TTY Biopharm | TPEX | Healthcare | Pharmaceuticals | NT$20.02B | 13.8x | 0.48 | NT$80.50 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -3.2% Downside | Upgrade to Pro+ | |
Universal Vision BioTech | TPEX | Healthcare | Healthcare Equipment & Supplies | NT$19.66B | 18.5x | 10 | NT$232 | -1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -9.1% Downside | Upgrade to Pro+ | |
SPT | Taiwan | Healthcare | Pharmaceuticals | NT$17.95B | 52.8x | 2.72 | NT$22.70 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 5.3% Upside | Upgrade to Pro+ | |
Sunmax BioTech | TPEX | Healthcare | Biotechnology & Medical Research | NT$17.84B | 25.5x | 1.16 | NT$327.50 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Tanvex BioPharma | Taiwan | Healthcare | Biotechnology & Medical Research | NT$17.03B | -6.5x | -0.32 | NT$71.50 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Medigen Vaccine Biologics | TPEX | Healthcare | Pharmaceuticals | NT$16.70B | -26x | -0.49 | NT$50.80 | 3.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
PharmaEngine | TPEX | Healthcare | Biotechnology & Medical Research | NT$15.37B | 8.8x | 0.02 | NT$107 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 12.1% Upside | Upgrade to Pro+ | |
OBI Pharma | TPEX | Healthcare | Biotechnology & Medical Research | NT$15.04B | -6.1x | 0.05 | NT$57.20 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Y.S.H. | Taiwan | Healthcare | Pharmaceuticals | NT$14.86B | 14.5x | 0.3 | NT$55.80 | 2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Excelsior | Taiwan | Healthcare | Healthcare Equipment & Supplies | NT$14.54B | 18.9x | 2.53 | NT$89 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -3.9% Downside | Upgrade to Pro+ | |
Synmosa Biopharma | TPEX | Healthcare | Pharmaceuticals | NT$13.95B | 19.4x | 1.12 | NT$33.20 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 8.3% Upside | Upgrade to Pro+ | |
Taidoc Tech | Taiwan | Healthcare | Healthcare Equipment & Supplies | NT$13.40B | 15.1x | -0.49 | NT$140.50 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 6.8% Upside | Upgrade to Pro+ | |
Foresee Pharmas | TPEX | Healthcare | Biotechnology & Medical Research | NT$13.08B | -12.4x | -1.93 | NT$84.50 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Gongwin Biopharm | TPEX | Healthcare | Biotechnology & Medical Research | NT$13.04B | -117.7x | -3.14 | NT$103 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Handa Pharmas | TPEX | Healthcare | Pharmaceuticals | NT$12.28B | 26.9x | -1.27 | NT$87 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
CHO Pharma | TPEX | Healthcare | Pharmaceuticals | NT$12.11B | -57.2x | -1.62 | NT$56.60 | -1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Lin Bio | TPEX | Healthcare | Pharmaceuticals | NT$11.84B | -15.3x | 0.49 | NT$149.50 | 1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
SCPC | Taiwan | Healthcare | Pharmaceuticals | NT$11.29B | 13.3x | NT$63.20 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 27.2% Upside | Upgrade to Pro+ | ||
SCI Pharmtech | Taiwan | Healthcare | Pharmaceuticals | NT$9.97B | 18.7x | 1.27 | NT$83.40 | -0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 7% Upside | Upgrade to Pro+ | |
St.Shine Optical | TPEX | Healthcare | Healthcare Equipment & Supplies | NT$9.78B | 15.6x | 9.42 | NT$194 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 27.4% Upside | Upgrade to Pro+ | |
ADIM | Taiwan | Healthcare | Pharmaceuticals | NT$9.46B | -15.6x | 0.06 | NT$22.45 | 1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 4.3% Upside | Upgrade to Pro+ | |
Easywell Biomedical | TPEX | Healthcare | Pharmaceuticals | NT$9.44B | -76x | -3.48 | NT$77.50 | -4.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Bioteque | TPEX | Healthcare | Healthcare Equipment & Supplies | NT$9.04B | 18.1x | 2.19 | NT$130.50 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
United Orthopedic | TPEX | Healthcare | Healthcare Equipment & Supplies | NT$8.87B | 19.1x | 1.32 | NT$92 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 37.4% Upside | Upgrade to Pro+ | |
SVBI | Taiwan | Healthcare | Healthcare Equipment & Supplies | NT$8.83B | 35x | 1.15 | NT$123 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 23.9% Upside | Upgrade to Pro+ | |
Mycenax Biotech | TPEX | Healthcare | Biotechnology & Medical Research | NT$8.68B | -16.1x | -0.65 | NT$42 | 1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Formosa Lab | Taiwan | Healthcare | Pharmaceuticals | NT$8.62B | 21.9x | 0.48 | NT$71.70 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
CHC Healthcare | Taiwan | Healthcare | Healthcare Equipment & Supplies | NT$8.61B | 26.5x | 3.83 | NT$51.60 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 6.8% Upside | Upgrade to Pro+ | |
Taigen BioPharmas | TPEX | Healthcare | Pharmaceuticals | NT$7.97B | 46.4x | 0.23 | NT$11.10 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Orient Pharma | TPEX | Healthcare | Pharmaceuticals | NT$7.92B | 66.5x | 0.2 | NT$35.50 | -1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Panion BF Biotech | Taiwan | Healthcare | Pharmaceuticals | NT$7.18B | 57.8x | 0.17 | NT$83.80 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 8.4% Upside | Upgrade to Pro+ | |
Pacific Hospital Supply | TPEX | Healthcare | Healthcare Equipment & Supplies | NT$6.80B | 15.2x | -1.95 | NT$93.70 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Savior Lifetec | TPEX | Healthcare | Pharmaceuticals | NT$6.49B | 36.1x | 0.09 | NT$20.45 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Hi-Clearance | TPEX | Healthcare | Healthcare Equipment & Supplies | NT$6.41B | 17.3x | 20.44 | NT$144 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Onyx Healthcare | TPEX | Healthcare | Healthcare Equipment & Supplies | NT$6.04B | 33.4x | -1.09 | NT$156.50 | 1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Sinphar | Taiwan | Healthcare | Pharmaceuticals | NT$5.72B | 17.2x | 0.84 | NT$31.60 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -1.9% Downside | Upgrade to Pro+ | |
Icares Medicus | TPEX | Healthcare | Healthcare Equipment & Supplies | NT$5.64B | 84.9x | -1.44 | NT$132.50 | 4.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Intai Tech | TPEX | Healthcare | Healthcare Equipment & Supplies | NT$5.42B | 20.3x | -0.58 | NT$109 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Medigen BioTech | TPEX | Healthcare | Biotechnology & Medical Research | NT$4.87B | -11.8x | -0.38 | NT$34.95 | 1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
SYN-Tech Chem & Pharm | TPEX | Healthcare | Pharmaceuticals | NT$4.68B | 11.9x | 0.45 | NT$105 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |